Transparency

Bristol-Myers Squibb is widely recognised for excellence in providing some of the world’s most important medicines for patients. At the same time, we strive to be transparent by providing information about treatments we are studying, whether they are investigational compounds, or new indications for existing marketed products.

At Bristol-Myers Squibb we work in partnership with lots of organisations to meet the needs of patients and the NHS. Bristol-Myers Squibb is committed to working in partnership with others in a way which is fully compliant with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice. Our objective is to act transparently with all stakeholders and the community at large.

Please use the links below for further information:
Clinical trials
Working with healthcare professionals
Working with patient groups

Date of preparation: May 2015 MLTUK1500052-05